scispace - formally typeset
M

Marina Sirota

Researcher at University of California, San Francisco

Publications -  174
Citations -  11162

Marina Sirota is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 28, co-authored 133 publications receiving 8803 citations. Previous affiliations of Marina Sirota include Lucile Packard Children's Hospital & Gladstone Institutes.

Papers
More filters
Journal ArticleDOI

Evolution of genes and genomes on the Drosophila phylogeny.

Andrew G. Clark, +429 more
- 08 Nov 2007 - 
TL;DR: These genome sequences augment the formidable genetic tools that have made Drosophila melanogaster a pre-eminent model for animal genetics, and will further catalyse fundamental research on mechanisms of development, cell biology, genetics, disease, neurobiology, behaviour, physiology and evolution.
Journal ArticleDOI

Identifying a high fraction of the human genome to be under selective constraint using GERP

TL;DR: GERP++ is an efficient and effective tool to provide both nucleotide- and element-level constraint scores within deep multiple sequence alignments, and is predicted to predict a higher fraction than earlier estimates largely due to the annotation of longer constrained elements, which improves one to one correspondence between predicted elements with known functional sequences.
Journal ArticleDOI

Ten years of pathway analysis: current approaches and outstanding challenges.

TL;DR: The evolution of knowledge base–driven pathway analysis over its first decade is discussed, distinctly divided into three generations, and a number of annotation challenges that must be addressed to enable development of the next generation of pathway analysis methods are identified.
Journal ArticleDOI

Systematic pan-cancer analysis of tumour purity

TL;DR: A systematic analysis using different measurement modalities of tumour purity in >10,000 samples across 21 cancer types from the Cancer Genome Atlas finds an immunotherapy gene signature in several cancer types that is not detected by traditional differential expression analyses.
Journal ArticleDOI

Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

TL;DR: A systematic computational approach to predict novel therapeutic indications on the basis of comprehensive testing of molecular signatures in drug-disease pairs for repositioning established drugs to treat a wide range of human diseases.